Pop Test Oncology LLC: Clinical Trials

4 trials sponsored by Pop Test Oncology LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Recruiting 1
Phase 21Not yet recruiting 1

Follow Pop Test Oncology LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans
PT150, Placebo - PTSD - Post Traumatic Stress Disorder
Phase 2Not yet recruitingSan Diego Veterans Healthcare System1202026-04-012025-12-23
PT150 Drug for Use in Alcohol Use Disorder
alcohol, Stress-Induction, PT150 - Alcohol Use Disorder
Phase 1RecruitingPop Test Oncology LLC342025-02-012026-09-16
Effects of Ethanol on the Pharmacokinetics of PT-150 (Formerly ORG34517) (PT150 PK Study)
PT150, Beverage - Potential Treatment for Alcohol Dependence-Alcohol Interaction
Phase 1CompletedPop Test Oncology LLC102021-11-012023-12-04
Clinical Trial to Evaluate the Safety of PT150 (Formerly ORG34517) When it is Taken Concurrently With Alcohol
PT150, Beverage - Alcohol Dependence, Alcohol Interaction
Phase 1CompletedPop Test Oncology LLC102018-09-012019-08-22

Conditions studied

Alcoholism (3)  ·  Alcohol Drinking (2)  ·  Combat Disorders (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Substance-Related Disorders (1)  ·  Wounds and Injuries (1)

Interventions

(11R,13S,17S)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-one (4)  ·  Beverages (2)  ·  Ethanol (1)

Countries

United States (4)

Top investigators

Christopher Verrico, PhD (1)  ·  Mark Fillmore, PhD (1)  ·  Victoria Risbrough, PhD (1)

Results publications

PMID 33972573

NIH funding

R01AA030774 (1)